Skip to main content
SpringerLink
Log in

Impact of depression and its treatment on the bones of growing children

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Depression in adults has been linked to reduced bone mineral density (BMD), osteoporosis, and increased incidence of fractures. Physiologic factors, such as hypothalamic-pituitary-adrenal axis dysfunction and increased circulation of inflammatory cytokines, may adversely impact bone metabolism. In addition, behavioral factors, such as reduced physical activity and altered dietary intake (especially of bone-related nutrients such as calcium and vitamin D), may be implicated. Antidepressant medications also may have an impact on BMD. Childhood and adolescence may be times of particular vulnerability to the adverse effects of depression due to the rapid bone mineral accrual that occurs during periods of growth. This article will review potential contributing factors and resulting consequences of depression on BMD in these populations and also explore areas of needed research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285: 785–795.

    Article  Google Scholar 

  2. Chan GM, Hoffman K, McMurry M: Effects of dairy products on bone and body composition in pubertal girls. J Pediatr 1995, 126: 551–556.

    Article  PubMed  CAS  Google Scholar 

  3. Bailey DA, McKay HA, Mirwald RL, et al.: A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study. J Bone Miner Res 1999, 14: 1672–1679.

    Article  PubMed  CAS  Google Scholar 

  4. Michelson D, Stratakis C, Hill L, et al.: Bone mineral density in women with depression. N Engl J Med 1996, 335: 1176–1181.

    Article  PubMed  CAS  Google Scholar 

  5. Schweiger U, Deuschle M, Korner A, et al.: Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 1994, 151: 1691–1693.

    PubMed  CAS  Google Scholar 

  6. Schweiger U, Weber B, Deuschle M, Heuser I: Lumbar bone mineral density in patients with major depression: evidence of increased bone loss at follow-up. Am J Psychiatry 2000, 157: 118–120.

    PubMed  CAS  Google Scholar 

  7. Mussolino M: Depression and hip fracture risk: the NHANES I Epidemiologic follow-up study. Public Health Rep 2005, 120: 71–75.

    PubMed  Google Scholar 

  8. Furlan PM, Ten Have T, Cary M, et al.: The role of stressinduced cortisol in the relationship between depression and decreased bone mineral density. Biol Psychiatry 2005, 57: 911–917.

    Article  PubMed  CAS  Google Scholar 

  9. Raison CL, Miller AH: When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003, 160: 1554–1565.

    Article  PubMed  Google Scholar 

  10. Penninx BW, Kritchevsky SB, Yaffe K, et al.: Inflammatory markers and depressed mood in older persons: results from the Health, Aging, and Body Composition study. Biol Psychiatry 2003, 54: 566–572.

    Article  PubMed  CAS  Google Scholar 

  11. Sugimoto T: Calcium intake and bone mass [in Japanese]. Clin Calcium 2001, 11: 193–197.

    PubMed  CAS  Google Scholar 

  12. Horrobin DF, Bennett CN: Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999, 60: 217–234.

    Article  PubMed  CAS  Google Scholar 

  13. Birmaher BD, Ryan ND, Williamson DE, et al.: Childhood and adolescent depression: a review of the past 10 years: Part I. J Am Acad Child Adolesc Psychiatry 1996, 35: 1427–1439.

    Article  PubMed  CAS  Google Scholar 

  14. Birmaher B, Arbelaez C, Brent D: Course and outcome of child and adolescent major depressive disorder. Child Adolesc Psychiatr Clin N Am 2002, 11: 619–637.

    Article  PubMed  Google Scholar 

  15. Johnston CC, Jr, Longcope C: Premenopausal bone loss—a risk factor for osteoporosis. N Engl J Med 1990, 323: 1271–1273.

    Article  PubMed  Google Scholar 

  16. Matkovic V, Jelic T, Wardlaw GM, et al.: Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994, 93: 799–808.

    Article  PubMed  CAS  Google Scholar 

  17. Halbreich U, Asnis GM, Shindledecker R, et al.: Cortisol secretion in endogenous depression. I: Basal plasma levels. Arch Gen Psychiatry 1985, 42: 904–908.

    PubMed  CAS  Google Scholar 

  18. Canalis E: Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996, 81: 3441–3447.

    Article  PubMed  CAS  Google Scholar 

  19. Manolagas SC, Weisterin RS: New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 1999, 14: 1061–1066.

    Article  PubMed  CAS  Google Scholar 

  20. Isaksson O: GH, IGF-I, and growth. J Pediatr Endocrinol 2004, 17(Suppl 4): 1321–1326.

    CAS  Google Scholar 

  21. Gold P, Goodwin F, Chrousos G: Clinical and biochemical manifestations of depression in an older population. J Am Geriatr Soc 2001, 49: 732–736.

    Article  Google Scholar 

  22. Kudo O, Fujikawa Y, Itonaga I, et al.: Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J Pathol 2002, 198: 220–227.

    Article  PubMed  CAS  Google Scholar 

  23. Kudo O, Sabokbar A, Pocock A, et al.: Interleukin-6 and interleukin-11 support human osteoclast formation by RANKL-independent mechanism. Bone 2003, 32: 1–7.

    Article  PubMed  CAS  Google Scholar 

  24. Steptoe A, Kunz-Ebrecht S, Owen N: Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003, 33: 667–674.

    Article  PubMed  CAS  Google Scholar 

  25. Kagaya A, Kugaya A, Takebayashi M, et al.: Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001, 43: 59–62.

    Article  PubMed  CAS  Google Scholar 

  26. Herran A, Amado J, Garcia-Unzueta M, et al.: Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 2000, 62: 779–782.

    PubMed  CAS  Google Scholar 

  27. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80(6 Suppl): 1678S–1688S.

    PubMed  CAS  Google Scholar 

  28. Sun D, Krishnan A, Zaman K, et al.: Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003, 18: 1206–1216.

    Article  PubMed  CAS  Google Scholar 

  29. Simonsick EM: Personal health habits and mental health in a national probability sample. Am J Prev Med 1991, 7: 425–437.

    PubMed  CAS  Google Scholar 

  30. Gustavsson A, Thorsen K, Nordstrom P: A 3-year longitudinal study of the effect of physical activity on the accrual of bone mineral density in healthy adolescent males. Calcif Tissue Int 2003, 73: 108–114.

    Article  PubMed  CAS  Google Scholar 

  31. Glassman AH, Helzer JE, Covey LS, et al.: Smoking, smoking cessation, and major depression. JAMA 1990, 264: 1546–1549.

    Article  PubMed  CAS  Google Scholar 

  32. Schoenborn CA, Horm J: Negative moods as correlates of smoking and heavier drinking: implications for health promotion. Adv Data 1993, 236: 1–16.

    PubMed  Google Scholar 

  33. Kleerekoper M, Schiebinger RJ: Skeletal recovery after treatment of Cushing’s: still room for improvement. J Clin Endocrinol Metab 1995, 80: 2856–2858.

    Article  Google Scholar 

  34. Liu B, Anderson G, Mittmann N, et al.: Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 1998, 351: 303–307.

    Article  Google Scholar 

  35. Misra M, Papakostas GI, Klibanski A: Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 2004, 65: 1607–1618.

    Article  PubMed  CAS  Google Scholar 

  36. Bachrach LK: Acquisition of optimal bone mass in childhood and adolescence. Trends Endocrinol Metab 2001, 12: 22–28.

    Article  PubMed  CAS  Google Scholar 

  37. Bonjour JP, Chevalley T, Ferrari S, Rizzoli R: Peak bone mass and its regulation. In Pediatric Bone Loss and Diseases. Edited by Glorieux F, Pettifor J, Juppner H. San Diego: Academic Press; 2003: 235–248.

    Google Scholar 

  38. Dahl RE, Birmaher B, Williamson DE, et al.: Low growth hormone response to growth hormone-releasing hormone in child depression. Biol Psychiatry 2000, 48: 981–988.

    Article  PubMed  CAS  Google Scholar 

  39. Monson JP, Drake WM, Carroll PV, et al.: Influence of growth hormone on accretion of bone mass. Horm Res 2002, 58(Suppl 1): 52–56.

    Article  PubMed  CAS  Google Scholar 

  40. Luby JL, Heffelfinger A, Mrakotsky C, et al.: Alterations in stress cortisol reactivity in depressed preschoolers relative to psychiatric and no-disorder comparison groups. Arch Gen Psychiatry 2003, 60: 1248–1255.

    Article  PubMed  Google Scholar 

  41. Di Somma C, Pivonello R, Loche S, et al.: Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol 2002, 56: 153–158.

    Article  Google Scholar 

  42. Leong GM, Mercado-Asis LB, Reynolds JC, et al.: The effect of Cushing’s disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair. J Clin Endocrinol Metab 1996, 81: 1905–1911.

    Article  PubMed  CAS  Google Scholar 

  43. Hirota K, Hirota T: Nutrition-related bone disease [in Japanese]. Nippon Rinsho 2006, 64: 1707–1711.

    PubMed  Google Scholar 

  44. Bar-Or O: Nutritional considerations for the child athlete. Can J Appl Physiol 2001, 26(Suppl): S186–S191.

    PubMed  Google Scholar 

  45. Bonjour JP, Carrie AL, Ferrari S, et al.: Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest 1997, 99: 1287–1294.

    Article  PubMed  CAS  Google Scholar 

  46. Lee WT, Leung SS, Leung DM, et al.: Bone mineral acquisition in low calcium intake children following the withdrawal of calcium supplement. Acta Paediatrica 1997, 86: 570–576.

    Article  PubMed  CAS  Google Scholar 

  47. MacKelvie KJ, Khan KM, Petit MA, et al.: A school-based exercise intervention elicits substantial bone health benefits: a two-year randomized controlled trial in girls. Pediatrics 2003, 112: e447.

    Article  PubMed  Google Scholar 

  48. MacKelvie KJ, Petit MA, Khan KM, et al.: Bone mass and structure are enhanced following a 2-year randomized controlled trial of exercise in prepubertal boys. Bone 2004, 34: 755–764.

    Article  PubMed  Google Scholar 

  49. Brosnahan J, Steffen LM, Lytle L, et al.: The relation between physical activity and mental health among Hispanic and non-Hispanic white adolescents. Arch Pediatr Adolesc Med 2004, 158: 818–823.

    Article  PubMed  Google Scholar 

  50. Warden SJ, Robling AG, Sanders MS, et al.: Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005, 146: 685–693.

    Article  PubMed  CAS  Google Scholar 

  51. Weintrob N, Cohen D, Klipper-Aurbach Y, et al.: Decreased growth during therapy with selective serotonin reuptake inhibitors. Arch Pediatr Adolesc Med 2002, 156: 696–701.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, Thomas Jefferson University Hospital, 833 Chestnut Street East, Suite 210, Philadelphia, PA, 19107, USA

    Angelica L. Kloos

Authors
  1. Elizabeth B. Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald A. Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Angelica L. Kloos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stacie Hitchcock
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Woo J. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Babette Zemel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angelica L. Kloos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weller, E.B., Weller, R.A., Kloos, A.L. et al. Impact of depression and its treatment on the bones of growing children. Curr Psychiatry Rep 9, 94–98 (2007). https://doi.org/10.1007/s11920-007-0077-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-007-0077-8

Keywords

Search

Navigation